Germany· DE-A57-28f3aaaa36071f5b
Capval Saft
A medicinal product containing noscapine ujotit ksh-4, registered in Germany by Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Noscapine Ujotit Ksh-4
- Manufacturer
- Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- August 5, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Noscapine ujotit ksh-4 in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsEtos Hoestdrank Noscapine HCl 1 mg/ml, stroopHealthypharm B.V.
- BelgiumNosca-Mereprine 1 mg/mlCooper Consumer Health
- SwitzerlandGEM Hustenstiller mit Noscapinum 10 mg, PastillenTentan AG
- SwedenNipaxon 2,5 mg/ml Oral suspensionMcNeil Sweden AB
- SpainTUSCALMAN 15 mg SUPOSITORIOS NIÑOSLaboratorio Farmaceutico S.I.T. - Specialita' Igienico Terapeutiche S.R.L.
- NorwayNoskapinOrifarm Healthcare A/S
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Belgium · Nosca-Méréprine
- Denmark · Noskapin Dak
- Spain · Tuscalman, Tuscalman Ninos
- Luxembourg · Nosca Méréprine, Nosca-Méréprine
- Netherlands · Hoestdrank Noscapine Hcl Etos, Hoestdrank Noscapine Hcl Htp
- Norway · Noskapin Orifarm Healthcare
- Sweden · Nipaxon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/70d65688-2aa0-44e0-be7c-d37128a54da8 GET /v1/drugs/70d65688-2aa0-44e0-be7c-d37128a54da8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Noscapine Ujotit Ksh-4",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about noscapine ujotit ksh-4.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.